Athenex is a global specialty oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies.
The company is dedicated to delivering innovative drugs that can have a life-changing impact on cancer patients. Our business includes medical technology innovation centers and a unique manufacturing supply chain across both China and North America. Through this connected innovation and manufacturing supply chain presence, we can identity, develop and deliver proprietary medical technology across continents and multiple regulatory environments.
Athenex currently has 10 innovative, proprietary products under development throughout the world with multiple offices in China and the US. Our employees include several hundred dedicated professionals to the mission of improving the lives of cancer patients throughout the world, through the discovery, development and commercialization of innovative oncology products and therapeutic solutions.
In addition to multiple offices in China and the US, we have regional development partners in Dunedin New Zealand, Hong Kong, Guangzhou China, Seoul South Korea, Taipei Taiwan, Buenos Aires Argentina, and Guatemala City Guatemala.